Protists as opportunistic pathogens: Public health impact in the 1990s and beyond

Journal of Eukaryotic Microbiology

Volumn 47, Issue 1, 2000, Pages 15-20

  Kaplan, Jonathan E ^a,b,c   Jones, Jeffrey L ^b,c   Dykewicz, Clare A ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cryptococcosis; Cryptosporidiosis; Fungus; HIV; Isosporiasis; Opportu nistic infections; PCP; Protozoa; Toxoplasmosis; Transplantation

Indexed keywords

ASPERGILLOSIS; CANDIDIASIS; COCCIDIOSIS; CRYPTOCOCCOSIS; CRYPTOSPORIDIOSIS; FUNGAL INFECTION; HAZARD ASSESSMENT; HUMAN IMMUNODEFICIENCY VIRUS; OPPORTUNISTIC PATHOGEN; ORGAN TRANSPLANTATION; PNEUMOCYSTIS CARINII; PROTOZOAL INFECTION; RISK ASSESSMENT; TOXOPLASMOSIS; UNITED STATES;

FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS CARINII; PROTISTA; PROTOZOA;

EID: 0033971835     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2000.tb00004.x     Document Type: Article

References (26)

1. Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., Emmons, C., Senterfitt, J. W., Berk, M. L., Morton, S. C. & Shapiro, M. F. 1998. The care of HIV-infected adults in the United States. N. Engl. J. Med. 339:1897-1904.
2. Bryan, R. T. 1995. Microsporidiosis as an AIDS-related opportunistic infection. Clin. Infect. Dis., 21(Suppl. 1):S62-S65.
3. Centers for Disease Control. 1989. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR, 38(No. S-5):1-9.
4. Centers for Disease Control and Prevention. 1994. Addressing Emerging Infectious Disease Threats. A Prevention Strategy for the United States. Atlanta, Georgia.
5. Centers for Disease Control and Prevention. 1998. Preventing Emerging Infectious Diseases. A Strategy for the 21st Century. Atlanta, Georgia.
6. Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H., Graybill, J. R., Sugar, A. M., Catanzaro, A., Gallis, H., Perfect, J. R., Dockery, B., Dismukes, W. E. & Stevens, D. A. 1994. NIAID Mycosis Study Group multicenter trial of oral intraconazole therapy for invasive aspergillosis. Am. J. Med., 97:135-144.
7. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox. B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., Powderly, W. G., Silber, J. L., Horowitz, H., Lichtin, A., Wolff, S. N., Mangan, K. F., Silver, S. M., Weisdorf, D., Ho, W. G., Gilbert, G. & Buell, D. 1992. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med., 326:845-851.
8. Goodrich, J. M., Reed, E. C., Mori, M., Fisher, L. D., Skerrett, S., Dandliker, P. S., Klis, B., Counts, G. W. & Meyers, J. D. 1991. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J. Infect. Dis., 164:731-740.
9. Hajjeh, R. A. 1995. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin. Infect. Dis., 21(Suppl. 1): S108-S110.
10. Institute of Medicine. 1992. Emerging Infections. Microbial Threats to Health in the United States. National Academy Press, Washington, D.C.
11. Jones, J. L., Hanson, D. L., Dworkin, M. S., Alderton, D. L., Fleming, P. L., Kaplan, J. E. & Ward, J. 1999. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. In CDC Surveillance Summaries (April 16, 1999). MMWR, 48(No. SS-2):1-22.
12. Kaplan, J. E., Masur, H., Holmes, K. K., McNeil, M. M., Schonherger, L. B., Navin, T.R., Hanson, D. L., Gross, P. A. & Jaffe, H. W. 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. Clin. Infect. Dis., 21(Suppl. 1):S1-S11.
13. Kaplan, J. E., Hu, D. J., Holmes, K. K., Jaffe, H. W., Masur, H. & De Cock, K. M. 1996. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am. J. Trop. Med. Hyg., 55:1-11.
14. Kaplan, J. E., Hanson, D. L., Jones, J. L., Beard, C. B., Juranek, D. D. & Dykewicz, C. A. 1998. Opportunistic infections (OIs) as emerging infectious diseases: challenges posed hy OIs in the 1990s and beyond. In: Scheld, W. M., Craig, W. A., Hughes, J. M. (ed.), Emerging Infections 2. ASM Press, Washington, D.C., p. 257-272.
15. Karon, J. M., Rosenberg, P. S., McQuillan, G., Khare, M., Gwinn, M. & Petersen, L. R. 1996. Prevalence of HIV infection in the United States, 1984-1992. JAMA. 276:126-131.
16. Kaur, A., Babu, P. G., Jacob, M., Narasimhan, C., Ganesh, A., Saraswathi, N. K., Mathai, D., Pulimood, B. M. & John, T. J. 1992. Clinical and laboratory profile of AIDS in India. J. Acquir. Immune Defic. Syndr., 5:883-889.
17. Laguna, F., Adrados, M., Alvar, J., Soriano, V., Valencia, M. E., Moreno, V., Polo, R., Verdejo, J., Jimenez, M. I., Martinez, P., Martinez, M. L. & Gonzalez-Lahoz, J. M. 1997. Visceral leishmaniasis in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol Infect. Dis., 16:898-903.
18. Lucas, S. B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., N'Gbichi, J., Yeboue, K., Honde, M., Diomande, M., Giordano, C., Doorly, R., Brattegaard, K., Kestens, L., Smithwick, R., Kadio, A., Ezani, N., Yapi, A. & DeCock, K. M. 1993. The mortality and pathology of HIV infection in a west African city. AIDS, 7:1569-1579.
19. McNeil, M. M. & Ampel, N. M. 1995. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin. Infect. Dis., 21(Suppl. 1):S111-S113.
20. Myers, J. D. 1990. Fungal infections in bone marrow transplant patients. Semin. Oncol. 17(Suppl. 6):10-13.
21. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D. & the HIV Out-patient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 338:853-860.
22. Rowlings, P. A., Passweg, J. R., Armitage, J. O., Gale, R. P., Sobocinski, K. A., Klein, J. P., Zhang, M. J. & Horowitz, M. M. 1996. Current status of allogeneic and autologous blood and marrow transplantation: report from the IBMTR and ABMTR-North America. In: Lanza, R. P., Chick, W. L. (ed.), Yearbook of Cell and Tissue Transplantation, 1996/1997. Kluwer Academic Publishers, The Netherlands, p. 19-34.
23. Silva, N., O'Bryan, L., Medeiros, E., Holand, H., Suleiman, J., Silva de Mendonca, J., Patronas, N., Reed, S. G., Klein, H. G., Masur, H. & Badaro, R., Trypanosoma cruzi meningoencephalitis in HIV-infected patients. 1999. J. Acquir. Immune Defic. Syndr. & Human Retr., 20:343-349.
24. Thongcharoen, P., Vitayasai, P., Vitayasai, V., Supparatpinyo, K. & Tansuphaswasdikul, S. 1992. Opportunistic infections in AIDS/HIV infected patients in Thailand. Thai AIDS J., 4:117-122.
25. UNAIDS Joint United Nations Programme on HIV/AIDS and World Health Organization. December 1998. AIDS Epidemic Update. Available from UNAIDS, Geneva, Switzerland.
26. Walter, E. A., Bowden, R. A. 1995. Infection in the bone marrow transplant recipient. In: Rubin, R. H. (ed.), Infection in Transplantation. Infectious Disease Clinics of North America. 9:823-847.